The mechanisms of smell loss after SARS-CoV-2 infection.

The mechanisms of smell loss after SARS-CoV-2 infection.
复制标题

SARS-CoV-2感染后嗅觉丧失的机制

DOI:
10.1016/s1474-4422(21)00202-7
复制
发表时间:
2021-09
期刊:
The Lancet. Neurology
影响因子:
--
通讯作者:
Doty RL
Doty RL
中科院分区:
其他
文献类型:
--
作者:
Doty RL

文献摘要

被引文献

相似文献

2 Mattsson N,Andreasson U,Zetterberg H,et al.阿尔茨海默病患者血浆神经丝光与神经变性的关联。JAMA Neurol 2017; 74:557-66. 3张文,王文,等.老年性痴呆患者血浆磷酸化tau蛋白181的检测及临床意义.中华神经科学杂志,2001,11:117 - 118. Nat Med 2020; 26:387-97. 4 Palmqvist S,Janelidze S,Quiroz YT,et al.血浆磷酸化tau 217对阿尔茨海默病与其他神经退行性疾病的鉴别准确性。JAMA 2020; 324:772-81. 5中村A,Kaneko N,Villemagne VL,et al.阿尔茨海默病的高效血浆淀粉样蛋白-β生物标志物。Nature 2018; 554:249-54.
2 Mattsson N, Andreasson U, Zetterberg H, et al. Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease. JAMA Neurol 2017; 74: 557–66. 3 Thijssen EH, La Joie R, Wolf A, et al. Diagnostic value of plasma phosphorylated tau181 in Alzheimer’s disease and frontotemporal lobar degeneration. Nat Med 2020; 26: 387–97. 4 Palmqvist S, Janelidze S, Quiroz YT, et al. Discriminative accuracy of plasma phospho-tau217 for alzheimer disease vs other neurodegenerative disorders. JAMA 2020; 324: 772–81. 5 Nakamura A, Kaneko N, Villemagne VL, et al. High performance plasma amyloid-β biomarkers for Alzheimer’s disease. Nature 2018; 554: 249–54.